Shopping Cart 0
Cart Subtotal
USD 0

Sanofi Pasteur SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sanofi Pasteur SA (Sanofi Pasteur), formerly Aventis Pasteur SA, a subsidiary of Sanofi, is a manufacturer and marketer of vaccines against bacterial and viral diseases. The company provides meningococcal vaccines and seasonal influenza vaccines. Its products are used in the treatment of cholera, diphtheria, haemophilus influenzae type b infections, meningococcal infections, pertussis, pneumococcal infections, tetanus, tuberculosis, typhoid fever, hepatitis A, hepatitis B, influenza, measles, mumps, poliomyelitis and rabies. The company operates in Algeria, Argentina, Australia, Austria, Belgium, Bangladesh, Brazil, Bulgaria, Canada, Chile, China, Malaysia, Pakistan, the Philippines, Russia, South Korea, Mexico and Indonesia, among others. Sanofi Pasteur is headquartered in Lyon, France.

Sanofi Pasteur SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sanofi Pasteur SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Sanofi Enters into Co-Development Agreement with MedImmune 10

Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 11

Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 12

Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 13

Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 14

Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 15

Sanofi Pasteur Enters Into Co-Development Agreement With Xiamen University For Universal Flu Vaccine 16

Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 17

Licensing Agreements 18

Sanofi Pasteur Enters into Licensing Agreement with Translate Bio 18

CureVac Enters into Licensing Agreement with Sanofi Pasteur to Develop mRNA-Based Prophylactic Vaccine 19

Sanofi Pasteur Expands Licensing Agreement With Vivalis 20

Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 21

Sanofi Pasteur SA-Key Competitors 22

Sanofi Pasteur SA-Key Employees 23

Sanofi Pasteur SA-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Joint Venture 25

Recent Developments 27

Corporate Communications 27

Jun 27, 2017: American Academy of Family Physicians Foundation Launches Highlight on VACCINATIONS 4 TEENS to Help Address Teen Under-Vaccination 27

Legal and Regulatory 28

Feb 06, 2018: Sanofi sued over alleged dengue vaccine death 28

Product News 29

Jun 13, 2018: Yellow fever: a new method for testing vaccine safety 29

Clinical Trials 30

Mar 15, 2018: H7N9 influenza vaccine clinical trials begin 30

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Key Facts 2

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sanofi Pasteur SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sanofi Pasteur SA, Deals By Therapy Area, 2012 to YTD 2018 8

Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Sanofi Enters into Co-Development Agreement with MedImmune 10

Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 11

Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 12

Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 13

Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 14

Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 15

Sanofi Pasteur Enters Into Co-Development Agreement With Xiamen University For Universal Flu Vaccine 16

Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 17

Sanofi Pasteur Enters into Licensing Agreement with Translate Bio 18

CureVac Enters into Licensing Agreement with Sanofi Pasteur to Develop mRNA-Based Prophylactic Vaccine 19

Sanofi Pasteur Expands Licensing Agreement With Vivalis 20

Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 21

Sanofi Pasteur SA, Key Competitors 22

Sanofi Pasteur SA, Key Employees 23

Sanofi Pasteur SA, Other Locations 24

Sanofi Pasteur SA, Subsidiaries 24

Sanofi Pasteur SA, Joint Venture 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sanofi Pasteur SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.